Кровотечения у больных с ишемической болезнью сердца при проведении терапии антиагрегантами

1. Ferreiro JL, Sibbing D, Angiolillo DJ. Platelet function test and risk of bleeding complications Thromb Haemostasis 2010; 103 (6): 111–6.
2. Hallas J, Doll M, Andries A et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: populationbased case-control study. BMJ. doi: 10.1136/bmj.38497.697558.AE (published online19.09.2006)
3. Eikelboom JW, Mehta SR, Anand SS, Xie C et al. Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes. Circulation 2006; 114 (8): 774–82.
4. Manokean SV. Predictorsand impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Am J Cardiol 2009; 104 (Suppl. 5): 9C–15C.
5. Feit F., Voeltz MD, Attubato MJ et al. Predictors and Impact of Major Hemorrhage on Mortality Following Percutaneous Coronary Intervention from the Replace-2 Trial. Am J Cardiol 2007; 100 (1364–9).
6. Wong P, Robinson A, Shaw S, Rodriges E. Long term clinical outcome and bleeding complications among hospital survivors with acute coronary syndromes. Postgrad Med J 2006; 82 (965): 224–7.
7. Mehran R, Pocock SJ, Nikolsky E et al. A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes. JACC 2010; 55 (23): 2556–66.
8. Subherwal S, Bach R, Chen A et al. Baseline Risk of Major Bleeding in Non ST-Segment Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the ACC/AHAguidelines) Bleeding Score. Circulation 2009; 119: 1873–82.
9. Rao AK, Pratt C, Berke A et al. Thrombolysis in Myocardial Infarction (TIMI) Trial- phase I: hemorrhagic manifestations and changes in plasma fibrinogen and fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. JACC 1988; 11 (1): 1–11.
10. The GUSTO Investigators. An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction. N Engl J Med 1993; 329 (10): 673–82.
12. Serebruany VL, Atar D. Assesment of bleeding events in clinical trials-proposal of a new classification. Am J Cardiol 2007; 99 (2): 288–90.
13. Serebruany VL, Rao SV, Silva MA, Donovan JL et al. Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classifications. Eur Heart J 2010; 31 (2): 227–35.
14. Usman MH, Notaro L, Nagarakanty R et al. Combination Antiplatalet Therapy for Secondary Stroke Prevention: Enhanced Efficacy or Double Trouble? Stroke 2009; 103: 1107–12.
15. Forest JA, Finlayson ND, Shearman DJ et al. Endoscopy in upper gastrointestinal bleeding. Lancet 1974; 2: 394–7.
16. Roy P, Bonello L, Torgusson R et al. Impact of «nuisance» bleeding on clopidogrel compliance in patients undergoing intracoronary drug-eluted stent implantation. Am J Cardiol 2008; 102 (12): 1614–7.
17. Waksman R. Definition, Incidence, Correlates, and Clinical Impact of «Nuisance» Bleeding in Patients Undergoing Drug-Eluted Stent Implantation. Am J Cardiol 2009; 104 (Suppl.): 30C–33C.
18. Ben-Dor I, Torgusos R, Scheinowitz M, Li Y et al. Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stent. Am Heart J 2010; 159 (5): 871–5.
19. Jernberg T, Paine CD, Winters KJ et al. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin treated patients with stable coronary artery disease. Eur Heart J 2006; 27: 1166–73.
20. Sumarokov AB, Buryachkovskaya LI, Uchitel IA, Shirokova TE. Minor bleeding in CHD patients receiving dual antiplatelet therapy. J Thromb Haemost 2009; 7 (Suppl. 2). Abstract PP-MO-770.
21. Сумароков А.Б., Бурячковская Л.И., Учитель И.А., Широкова Т.Е. Малые кровотечения у больных ИБС, получающих двойную антитромбоцитарную терапию. Кардиол. вестн. 2009; 4 (16, 2): 49–53.
22. Grines CL, Bonow RO, Casey DE et al. Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents: Ascience Advisory From the American Heart Association, American College of Cardiology, Sociaety for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, With Representation Fromthe American College of Physisions. Circulation 2007; 115: 813–8.
23.Отчет рабочей группы по стандартизации световой трансмиссионной агрегатометрии при комитете по физиологии тромбоцитов ISTH (2010). Материалы 56 ежегодной конференции ISTH по стандартизации. www.isth.org/default/assets/File/SSCMinutes/2010
24. Siller-Matula J, Huber K, Christ G et al. Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Heart 2011; 97: 98–105.

А.Б.Сумароков*1, Л.И.Бурячковская2, И.А.Учитель2

1 ГОУ ВПО Институт клинической кардиологии им А.Л.Мясникова Минздравсоцразвития РФ, Москва;
2 Институт экспериментальной кардиологии РКНПК Минздравсоцразвития РФ, Москва
*vokoramus@mail.ru

________________________________________________

A.B.Sumarokov*1, L.I.Buryachkovskaya2, I.A.Uchitel2

1 Department of Atherosclerosis problems, Institute of Clinical Cardiology named after AL. Myasnikov,
2 Laboratory of Adhesion Molecules, Institute of Experimental Cardiology, Ministry of Health and Social Development of the Russian Federation, Moscow
*vokoramus@mail.ru